Belsomra (Suvorexant) Side Effects: Withdrawal and Discontinuation Syndrome
A clinical deep-dive into suvorexant withdrawal, rebound insomnia, and discontinuation symptoms, with trial data, FDA label guidance, and physician-reviewed protocols.
V2 Suvorexant: Side Effects
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
6articles
2topic areas covered
Jul 10, 2025latest review
V2 Suvorexant: Side Effects library
Showing 6 of 6 clinical reviews.
Belsomra Side Effects: Delayed-Onset Adverse Events You Should Know
A clinical deep-dive into delayed-onset side effects of Belsomra (suvorexant), including next-day somnolence, sleep paralysis, complex sleep behaviors, and withdrawal effects, with data from FDA labeling, FAERS, and published trials.
Belsomra Side Effects: Incidence Rates Across Clinical Trials
A detailed breakdown of suvorexant (Belsomra) adverse event rates drawn from Phase 3 trials, the FDA prescribing label, FAERS reports, and post-marketing literature, with exact percentages and clinical context.
Belsomra Side Effects: Potentially Permanent Side Effects of Suvorexant
A physician-reviewed guide to Belsomra (suvorexant) side effects, including rare adverse events, potentially long-lasting effects, FAERS data, and clinical trial findings with primary-source citations.
Belsomra Side Effects: Rare but Serious Adverse Events You Need to Know
A clinically detailed review of rare but serious adverse events linked to Belsomra (suvorexant), including sleep paralysis, complex sleep behaviors, suicidal ideation, and more. Backed by trial data, FDA label language, and FAERS reports.
Belsomra Side Effects: Severity Distribution by Patient Phenotype
A clinician-reviewed breakdown of Belsomra (suvorexant) adverse events by severity level, patient population, dose, and comorbidity profile. Includes trial data, FAERS signals, and phenotype-specific risk tables.